Please Wait

Applying Filters...

Abbvie Header week 48

Abbvie Header week 48

X

Details of Polpharma's U.S. FDA Inspections. Original Data: FDA Inspection Database

Polpharma

About, Contact Details

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Product List 2021, Corporate Presentation, GMP Certificate 2022, API Product List 2021, FDF Product List 2019, Contract Manufacturing, CDMO

VIDEO(s)

Corporate Video, Polpharma Biologics - Brand Launch Video, Ideas Make It Happen, Polpharma API, Your European CDMO Partner

DIGITAL CONTENT

1 Interview #SpeakPharma, 130 News

APIs // Active Pharmaceutical Ingredients

83 APIs, 69 USDMF, 23 CEP/COS, 12 JDMF, 44 KDMF, 40 NDC API, 49 Listed APIs

DEVELOPMENTS

8 Drug(s) in Development

8 Drug(s) in Development

DOSSIERs // Finished Dosage Forms

258 Dossiers, 129 Europe, 129 Listed Dossiers

KEY PRODUCTS

Alendronate Sodium, Apixaban, Baclofen, Dapagliflozin, Dapagliflozin Propanediol Monohydrate, Empagliflozin, Hydrochlorothiazide, Linagliptin, Pentoxifylline, Piracetam, Rivaroxaban, Tadalafil, Ticagrelor, Zoledronic Acid

SERVICES

All Services, API Manufacturing, API & Drug Product Development

All Services
API Manufacturing
API & Drug Product Development
- 2 API Development
- 2 Preformulation & Material Science

KEY SERVICES

Scale Up

Scale Up

INSPECTIONS & REGISTRATIONS

4 FDA, 41 EDQM, 1 GDUFA

Polpharma
FDA
Full Screen View